Effects of alpha(1)-adrenoceptor antagonists on male sexual function

Drugs
Marleen M van DijkMartin C Michel

Abstract

alpha(1)-Adrenoceptor antagonists such as alfuzosin, doxazosin, tamsulosin and terazosin are first-line agents for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (BPH), but are only second-line agents (doxazosin and terazosin only) for the treatment of arterial hypertension. Sexual function is complex and includes multiple domains such as sexual desire (libido), erectile function and ejaculatory function. Erectile and ejaculatory functions are frequently reduced in patients with BPH and can impact on their quality of life. Therefore, the treatment of BPH should aim to maintain or even restore sexual function.alpha(1)-Adrenoceptor antagonists lack major effects on sexual desire in placebo-controlled studies. Reports on erectile function are inconsistent, with both beneficial and adverse effects being reported, but impotence can occur in some patients without clear differences between drugs. Ejaculatory dysfunction during treatment may represent (relative) an ejaculation. It occurs more frequently with tamsulosin than with other drugs of this class, but the differences are not big enough to be consistently detectable in directly comparative studies. We propose that such differences betwee...Continue Reading

References

May 23, 1986·The American Journal of Medicine·J H Mersey
Mar 21, 1998·The Journal of Urology·A J BeckerU Jonas
Sep 22, 1998·Journal of Clinical Epidemiology·S J FrankelA T Lin
Dec 20, 1999·Behavioural Brain Research·E M HullJ Moses
May 3, 2000·BJU International·S KregeM C Michel
Jun 26, 2001·British Journal of Clinical Pharmacology·M C MichelH Rübben
Aug 30, 2001·International Journal of Impotence Research·A ChoppinW J Hellstrom
Sep 8, 2001·The Journal of Urology·C C SchulmanUNKNOWN European Tamsulosin Study Group
Jun 7, 2002·The Journal of Urology·Herbert SperlingMartin C Michel
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·B LukacsC McCarthy

❮ Previous
Next ❯

Citations

Jul 12, 2012·Der Urologe. Ausg. A·F StrittmatterC Gratzke
Nov 9, 2006·World Journal of Urology·Th StadlerC G Stief
Mar 21, 2008·Cell and Tissue Research·Daniel Barboza Cava QueirózMaria Christina W Avellar
Jul 10, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·M RouprêtF Desgrandchamps
Jul 26, 2011·Asian Journal of Andrology·Sang Hoon SongNam Cheol Park
Dec 17, 2008·International Journal of Impotence Research·B-H ChungS-J Yoo
Jul 16, 2009·International Journal of Impotence Research·M C Michel, A Meissner
Jul 7, 2007·Nature Clinical Practice. Urology·Karl-Erik Andersson, Christian Gratzke
Mar 13, 2014·Journal of the American College of Nutrition·Donato CasamassimaLuigi Ambrosone
Oct 25, 2013·Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·M P J NicolaiH W Elzevier
Dec 3, 2013·Pharmacology, Biochemistry, and Behavior·K DecaluwéJ Van de Voorde
Jan 6, 2011·Expert Opinion on Therapeutic Targets·Ibrahim A Abdel-HamidAndrea Salonia
Mar 19, 2008·Expert Opinion on Pharmacotherapy·Vinod H Nargund, Alistair D R Grey
Nov 29, 2007·Expert Opinion on Investigational Drugs·Masaki YoshidaKazuki Kawabe
Oct 14, 2011·The Journal of Sexual Medicine·Jacques Buvat
Dec 19, 2012·Techniques in Vascular and Interventional Radiology·Luís Campos Pinheiro, João Martins Pisco
Mar 12, 2016·Investigative and Clinical Urology·Jeong Kyun YeoHyung Ji Kim
Mar 3, 2009·Life Sciences·Atsushi SanbeAkito Tanoue
Sep 20, 2008·Gynécologie, obstétrique & fertilité·G RobinJ-M Rigot
Sep 22, 2015·Life Sciences·Neide Hyppolito JurkiewiczMaria Christina Werneck Avellar
Jul 3, 2007·British Journal of Pharmacology·A SanbeA Tanoue
Jul 3, 2007·British Journal of Pharmacology·M C Michel
Mar 20, 2015·Autonomic & Autacoid Pharmacology·B J DavisR Chess-Williams
Apr 6, 2016·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Bogdan PajovicMarko Vukovic
Apr 24, 2016·Current Urology Reports·Michelle HerbertsTobias Köhler
Sep 23, 2014·The World Journal of Men's Health·Jae Hwi ChoiJae Seog Hyun

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.